TKIs effectively prevent auto-phosphorylation of EGFR and Her2 in tumor cells, however, the transphosphorylation of Her3 is only transiently suppressed and Her3 ultimately escapes inhibition by TKIs in Her2 over-expressing tumor cells[10]. This evidence concerns the gene EGFR and neoplasm.